Marfan's syndrome

Lancet

Volumn 366, Issue 9501, 2005, Pages 1965-1976

  Judge, Daniel P ^a   Dietz, Harry C ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENALAPRIL; FIBRILLIN 1; LOW MOLECULAR WEIGHT HEPARIN; PROPRANOLOL; PROTEIN INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; VERAPAMIL; WARFARIN;

AORTA ANEURYSM; AORTA DISSECTING ANEURYSM; AORTA ROOT; AORTA VALVE; ASTHMA; CARDIOVASCULAR SYSTEM; CELL ACTIVITY; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; DEPRESSION; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; DURA ECTASIA; ECTOPIA LENTIS; EMBRYOPATHY; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; FAMILY HISTORY; FATIGUE; FETUS DEATH; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GROWTH DISORDER; HEPARIN INDUCED THROMBOCYTOPENIA; HEREDITY; HUMAN; INTEGUMENT; LIFESTYLE; LONG BONE; MARFAN SYNDROME; MEDICAL CARE; MOLECULAR GENETICS; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROSTHESIS; PROTEIN DEFICIENCY; RESPIRATORY SYSTEM; SIDE EFFECT; SKELETON; SKIN; SPINE DISEASE; THROMBOEMBOLISM;

EID: 28244441145     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67789-6     Document Type: Conference Paper

References (109)

1. AB Marfan Un cas de deformation congenitale des quarte membres plus prononcee aux extremites caracterisee par l'allongement des os avec un certain degre d'amincissement Bull Mem Soc Med Hop Paris 13 1986 220 226
2. JR Gray, AB Bridges, MJ Faed Ascertainment and severity of Marfan syndrome in a Scottish population J Med Genet 31 1994 51 54
3. HC Dietz, GR Cutting, RE Pyeritz Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene Nature 352 1991 337 339
4. B Loeys, J De Backer, P De Acker Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome Hum Mutat 24 2004 140 146
5. N Kinoshita, J Mimura, C Obayashi, F Katsukawa, S Onishi, H Yamazaki Aortic root dilatation among young competitive athletes: echocardiographic screening of 1929 athletes between 15 and 34 years of age Am Heart J 139 2000 723 728
6. JL Murdoch, BA Walker, BL Halpern, JW Kuzma, VA McKusick Life expectancy and causes of death in the Marfan syndrome N Engl J Med 286 1972 804 808
7. DI Silverman, KJ Burton, J Gray Life expectancy in the Marfan syndrome Am J Cardiol 75 1995 157 160
8. P Beighton, A De Paepe, D Danks International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986 Am J Med Genet 29 1988 581 594
9. A De Paepe, RB Devereux, HC Dietz, RC Hennekam, RE Pyeritz Revised diagnostic criteria for the Marfan syndrome Am J Med Genet 62 1996 417 426
10. KN Joseph, HA Kane, RS Milner, NL Steg, MB Williamson Jr, JR Bowen Orthopedic aspects of the Marfan phenotype Clin Orthop Relat Res 277 1992 251 261
11. IH Maumenee The eye in the Marfan syndrome Trans Am Ophthalmol Soc 79 1981 684 733
12. VA McKusick The cardiovascular aspects of Marfan's syndrome Circulation 11 1955 321
13. HE Sisk, KG Zahka, RE Pyeritz The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age Am J Cardiol 52 1983 353 358
14. RE Pyeritz, MA Wappel Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history Am J Med 74 1983 797 807
15. WC Roberts, HS Honig The spectrum of cardiovascular disease in the Marfan syndrome: a clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients Am Heart J 104 1982 115 135
16. S Chen, LF Fagan, S Nouri, JL Donahoe Ventricular dysrhythmias in children with Marfan's syndrome Am J Dis Child 139 1985 273 276
17. A Savolainen, M Kupari, L Toivonen, I Kaitila, M Viitasalo Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome J Intern Med 241 1997 221 226
18. LJ Meijboom, J Timmermans, JP De Tintelen Evaluation of left ventricular dimensions and function in Marfan's syndrome without significant valvular regurgitation Am J Cardiol 95 2005 795 797
19. MJ Roman, RB Devereux, R Kramer-Fox, J O'Loughlin Two-dimensional echocardiographic aortic root dimensions in normal children and adults Am J Cardiol 64 1989 507 512
20. VL Gott, DE Cameron, DE Alejo Aortic root replacement in 271 Marfan patients: a 24-year experience Ann Thorac Surg 73 2002 438 443
21. VL Gott, PS Greene, DE Alejo Replacement of the aortic root in patients with Marfan's syndrome N Engl J Med 340 1999 1307 1313
22. PC Spittell, JA Spittell Jr, JW Joyce Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990) Mayo Clin Proc 68 1993 642 651
23. ME Debakey, WS Henly, DA Cooley, GC Morris, ES Crawford, AC Beal Surgical management of dissecting aneurysms of the aorta J Thorac Cardiovasc Surg 49 1965 130 149
24. EA Streeten, EA Murphy, RE Pyeritz Pulmonary function in the Marfan syndrome Chest 91 1987 408 412
25. JR Wood, D Bellamy, AH Child, KM Citron Pulmonary disease in patients with Marfan syndrome Thorax 39 1984 780 784
26. PR Cohen, P Schneiderman Clinical manifestations of the Marfan syndrome Int J Dermatol 28 1989 291 299
27. RE Pyeritz, EK Fishman, BA Bernhardt, SS Siegelman Dural ectasia is a common feature of the Marfan syndrome Am J Hum Genet 43 1988 726 732
28. GM Villeirs, AJ De Tongerloo, KL Verstraete, MF Kunnen, AM De Paepe Widening of the spinal canal and dural ectasia in Marfan's syndrome: assessment by CT Neuroradiology 41 1999 850 854
29. R Fattori, CA Nienaber, B Descovich Importance of dural ectasia in phenotypic assessment of Marfan's syndrome Lancet 354 1999 910 913
30. MJ Glesby, RE Pyeritz Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum JAMA 262 1989 523 528
31. RA Montgomery, MT Geraghty, E Bull Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome Am J Hum Genet 63 1998 1703 1711
32. P Tsipouras, R Del Mastro, M Sarfarazi Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study N Engl J Med 326 1992 905 909
33. CJ Vaughan, M Casey, J He Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder Circulation 103 2001 2469 2475
34. D Guo, S Hasham, SQ Kuang Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14 Circulation 103 2001 2461 2468
35. AN Gale, VA McKusick, GM Hutchins, VL Gott Familial congenital bicuspid aortic valve: secondary calcific aortic stenosis and aortic aneurysm Chest 72 1977 668 670
36. BL Loeys, J Chen, ER Neptune A syndrome of altered cardiovascular, craniofacial, neurocognitive, and skeletal development caused by mutations in TGFBR1 or TGFBR2 Nat Genet 37 2005 275 281
37. RJ Shprintzen, RB Goldberg A recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias J Craniofac Genet Dev Biol 2 1982 65 74
38. MT Greally, JC Carey, DM Milewicz Shprintzen-Goldberg syndrome: a clinical analysis Am J Med Genet 76 1998 202 212
39. J Furlong, TW Kurczynski, JR Hennessy New Marfanoid syndrome with craniosynostosis Am J Med Genet 26 1987 599 604
40. T Halme, T Savunen, H Aho, T Vihersaari, R Penttinen Elastin and collagen in the aortic wall: changes in the Marfan syndrome and annuloaortic ectasia Exp Mol Pathol 43 1985 1 12
41. T Tsuji Marfan syndrome: demonstration of abnormal elastic fibres in skin J Cutan Pathol 13 1986 144 153
42. S Takebayashi, I Kubota, T Takagi Ultrastructural and histochemical studies of vascular lesions in Marfan's syndrome, with report of 4 autopsy cases Acta Pathol Jpn 23 1973 847 866
43. K Kainulainen, L Pulkkinen, A Savolainen, I Kaitila, L Peltonen Location on chromosome 15 of the gene defect causing Marfan syndrome N Engl J Med 323 1990 935 939
44. MJ Fazio, MG Mattei, E Passage Human elastin gene: new evidence for localization to the long arm of chromosome 7 Am J Hum Genet 48 1991 696 703
45. LY Sakai, DR Keene, E Engvall Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils J Cell Biol 103 1986 2499 2509
46. K Kainulainen, B Steinmann, F Collins Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene Am J Hum Genet 49 1991 662 667
47. GM Corson, SC Chalberg, HC Dietz, NL Charbonneau, LY Sakai Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end Genomics 17 1993 476 484
48. NJ Biery, ZA Eldadah, CS Moore, G Stetten, F Spencer, HC Dietz Revised genomic organization of FBN1 and significance for regulated gene expression Genomics 56 1999 70 77
49. DP Reinhardt, DE Mechling, BA Boswell, DR Keene, LY Sakai, HP Bachinger Calcium determines the shape of fibrillin J Biol Chem 272 1997 7368 7373
50. DP Reinhardt, RN Ono, LY Sakai Calcium stabilizes fibrillin-1 against proteolytic degradation J Biol Chem 272 1997 1231 1236
51. DW Hollister, M Godfrey, LY Sakai, RE Pyeritz Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome N Engl J Med 323 1990 152 159
52. G Nijbroek, S Sood, I McIntosh Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons Am J Hum Genet 57 1995 8 21
53. HC Dietz, I McIntosh, LY Sakai Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome Genomics 17 1993 468 475
54. D Halliday, S Hutchinson, S Kettle, H Firth, P Wordsworth, PA Handford Molecular analysis of eight mutations in FBN1 Hum Genet 105 1999 587 597
55. DP Judge, NJ Biery, DR Keene Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome J Clin Invest 114 2004 172 181
56. S Hutchinson, A Furger, D Halliday Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype? Hum Mol Genet 12 2003 2269 2276
57. L Pereira, K Andrikopoulos, J Tian Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome Nat Genet 17 1997 218 222
58. L Pereira, SY Lee, B Gayraud Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1 Proc Natl Acad Sci USA 96 1999 3819 3823
59. TE Bunton, NJ Biery, L Myers, B Gayraud, F Ramirez, HC Dietz Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome Circ Res 88 2001 37 43
60. F Ramirez, DB Rifkin Cell signaling events: a view from the matrix Matrix Biol 22 2003 101 107
61. L Pereira, M D'Alessio, F Ramirez Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome Hum Mol Genet 2 1993 1762
62. J Saharinen, M Hyytiainen, J Taipale, J Keski-Oja Latent transforming growth factor-beta binding proteins (LTBPs) - structural extracellular matrix proteins for targeting TGF-beta action Cytokine Growth Factor Rev 10 1999 99 117
63. J Massague How cells read TGF-beta signals Nat Rev Mol Cell Biol 1 2000 169 178
64. ER Neptune, PA Frischmeyer, DE Arking Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome Nat Genet 33 2003 407 411
65. CM Ng, A Cheng, LA Myers TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome J Clin Invest 114 2004 1586 1592
66. KB Jones, L Myers, DP Judge, PA Kirby, HC Dietz, PD Sponseller Toward an understanding of dural ectasia: a light microscopy study in a murine model of Marfan syndrome Spine 30 2005 291 293
67. T Mizuguchi, G Collod-Beroud, T Akiyama Heterozygous TGFBR2 mutations in Marfan syndrome Nat Genet 36 2004 855 860
68. G Collod-Beroud, C Beroud, L Ades Marfan Database (third edition): new mutations and new routines for the software Nucleic Acids Res 26 1998 229 233
69. B Loeys, L Nuytinck, I Delvaux, S De Bie, A De Paepe Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome Arch Intern Med 161 2001 2447 2454
70. L Pereira, O Levran, F Ramirez A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome N Engl J Med 331 1994 148 153
71. DP Judge, NJ Biery, HC Dietz Characterization of microsatellite markers flanking FBN1: utility in the diagnostic evaluation for Marfan syndrome Am J Med Genet 99 2001 39 47
72. L Lonnqvist, A Child, K Kainulainen, R Davidson, L Puhakka, L Peltonen A novel mutation of the fibrillin gene causing ectopia lentis Genomics 19 1994 573 576
73. L Faivre, RJ Gorlin, MK Wirtz In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome J Med Genet 40 2003 34 36
74. N Dagoneau, C Benoist-Lasselin, C Huber ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome Am J Hum Genet 75 2004 801 806
75. ZA Eldadah, JA Grifo, HC Dietz Marfan syndrome as a paradigm for transcript-targeted preimplantation diagnosis of heterozygous mutations Nat Med 1 1995 798 803
76. JE Marr, J Halliwell-Ewen, B Fisher, L Soler, JR Ainsworth Associations of high myopia in childhood Eye 15 2001 70 74
77. A Loewenstein, IS Barequet, De Juan E Jr, IH Maumenee Retinal detachment in Marfan syndrome Retina 20 2000 358 363
78. KB Jones, G Erkula, PD Sponseller, JP Dormans Spine deformity correction in Marfan syndrome Spine 27 2002 2003 2012
79. PH Arn, LR Scherer, JA Haller Jr, RE Pyeritz Outcome of pectus excavatum in patients with Marfan syndrome and in the general population J Pediatr 115 1989 954 958
80. PM Quigley, JA Haller Jr, KL Jelus, GM Loughlin, CL Marcus Cardiorespiratory function before and after corrective surgery in pectus excavatum J Pediatr 128 1996 638 643
81. D Borowitz, F Cerny, G Zallen Pulmonary function and exercise response in patients with pectus excavatum after Nuss repair J Pediatr Surg 38 2003 544 547
82. OA Bawazir, M Montgomery, J Harder, DL Sigalet Midterm evaluation of cardiopulmonary effects of closed repair for pectus excavatum J Pediatr Surg 40 2005 863 867
83. ML Lawson, RB Mellins, M Tabangin Impact of pectus excavatum on pulmonary function before and after repair with the Nuss procedure J Pediatr Surg 40 2005 174 180 discussion 180
84. Nuss D, Kelly J, Robert E, Croitoru DP, Katz ME, A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J Pediatr Surg; 33: 545-52.
85. J Haller, PM Colombani, CT Humphries, RG Azizkhan, GM Loughlin Chest wall constriction after too extensive and too early operations for pectus excavatum Anns Thorac Surg 61 1996 1618 1625
86. BL Halpern, F Char, JL Murdoch, WB Horton, VA McKusick A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment Johns Hopkins Med J 129 1971 123 129
87. MA Salim, BS Alpert, JC Ward, RE Pyeritz Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome Am J Cardiol 74 1994 629 633
88. R Rossi-Foulkes, MJ Roman, SE Rosen Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome Am J Cardiol 83 1999 1364 1368
89. J Shores, KR Berger, EA Murphy, RE Pyeritz Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome N Engl J Med 330 1994 1335 1341
90. WL Henry, JM Gardin, JH Ware Echocardiographic measurements in normal subjects from infancy to old age Circulation 62 1980 1054 1061
91. AT Yetman, RA Bornemeier, BW McCrindle Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the marfan syndrome Am J Cardiol 95 2005 1125 1127
92. RR Davies, LJ Goldstein, MA Coady Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size Ann Thorac Surg 73 2002 17 27
93. H Bentall, A De Bono A technique for complete replacement of the ascending aorta Thorax 23 1968 338 339
94. J Bachet, JL Termignon, B Goudot Aortic root replacement with a composite graft. Factors influencing immediate and long-term results Eur J Cardiothorac Surg 10 1996 207 213
95. TE David, CM Feindel An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta J Thorac Cardiovasc Surg 103 1992 617 621 discussion 622
96. MA Sarsam, M Yacoub Remodeling of the aortic valve anulus J Thorac Cardiovasc Surg 105 1993 435 438
97. NC de Oliveira, TE David, J Ivanov Results of surgery for aortic root aneurysm in patients with Marfan syndrome J Thorac Cardiovasc Surg 125 2003 789 796
98. EJ Birks, C Webb, A Child, R Radley-Smith, MH Yacoub Early and long-term results of a valve-sparing operation for Marfan syndrome Circulation 100 1999 1129 1135
99. BT Bethea, TP Fitton, DE Alejo Results of aortic valve-sparing operations: Experience with remodeling and reimplantation procedures in 65 patients Ann Thorac Surg 78 2004 767 772
100. R De Paulis, GM De Matteis, P Nardi One-year appraisal of a new aortic root conduit with sinuses of Valsalva J Thorac Cardiovasc Surg 123 2002 33 39
101. AC Braverman Exercise and the Marfan syndrome Med Sci Sports Exerc 30 1998 S387 S395
102. BJ Maron, BR Chaitman, MJ Ackerman Recommendations for physical activity and recreational sports participation for young patients With genetic cardiovascular diseases Circulation 109 2004 2807 2816
103. RE Pyeritz Maternal and fetal complications of pregnancy in the Marfan syndrome Am J Med 71 1981 784 790
104. JP Rossiter, JT Repke, AJ Morales, EA Murphy, RE Pyeritz A prospective longitudinal evaluation of pregnancy in the Marfan syndrome Am J Obstet Gynecol 173 1995 1599 1606
105. Meijboom LJ, Vos FE, Timmermans J Pregnancy and aortic root growth in the Marfan syndrome: a prospective study Eur Heart J 26 2005 914 920
106. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves J Am Coll Cardiol 33 1999 1637 1641
107. Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R Low-molecular-weight heparin for prosthetic heart valves: treatment failure Ann Thorac Surg 69 2000 264 265
108. Ageno W, Crotti S, Turpie AG The safety of antithrombotic therapy during pregnancy Expert Opin Drug Saf 3 2004 113 118
109. Roberts N, Ross D, Flint SK, Arya R, Blott M Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin Bjog 108 2001 327 329